Cambridge Cognition Limited

A large, international research project called Bio-Hermes 2 aims to study Alzheimer's Disease by collecting data on digital and blood biomarkers (signs that can indicate if someone has the disease). The project wants to see how well these biomarkers match up with existing tests, such as PET scans, which show what's happening in the brain. Cambridge Cognit...

Schizophrenia affects about 1% of the population and is associated with enormous health and societal costs and personal suffering. The drugs that are available to treat schizophrenia don't work for many patients and can produce unpleasant side effects. They also don't help with some of the symptoms that trouble patients most, such as problems concentratin...

Chronic pain (pain lasting at least 3 months) affects around 1 in 3 people. While many painkillers are available, they do not work for everyone and often have undesirable side effects, including a risk of addiction. One reason it is difficult to develop better pain treatments is because there is no external way of measuring pain, other than by asking the ...

To develop an app that will help depressive people to manage their symptoms by learning to read other people's facial expressions and emotions more positively.

Most of the 700,000 people in the UK with dementia have not received a formal diagnosis, so are denied access to benefitial treatments. The current NHS approach is slow (often more than 12 months) and often of low quality. This project will develop a novel digital healthcare system that will allow dementia diagnoses to be made quickly, cost effectively, a...